An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week 72, orforglipron at multiple ...

The human bones found in the Thames are concentrated at the end of the prehistoric period, suggesting that they are ritual ...

Dr. Allison Winter secured a VeloSano grant after five years of rejected proposals for central nervous system lymphoma ...

Subscribe to Market Briefs for FREE and get my daily financial newsletter: My recommended tools*! *Please note: Yes, these ...

The Trump administration said it plans on making the citizenship test harder, establishing a higher bar for passing and ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure ...

Error bars illustrate the margin of error for a survey estimate by showing how precise that estimate is. Here are some answers to common questions that might help you better understand charts with ...

A growing body of research underscores that Alzheimer’s and cognitive decline are not inevitable parts of aging.

Results of a new study support using semaglutide and tirzepatide to reduce risk in patients with cardiometabolic heart failure with preserved ejection fraction.The study investigated the effectiveness ...

Half-Year Results and Business UpdatePositive Phase I data with TG4050 in operable Head and Neck Squamous Cell Carcinoma (HNSCC) 100% ...

Congress showed that vaccines against influenza and respiratory syncytial virus protect against adverse cardiovascular and ...

Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and ...